Polpharma is a Polish CDMO of APIs and a significant European API producer, delivering products to companies worldwide.

Contact Supplier

EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

Synopsis

ACTIVE PHARMA INGREDIENTS

API Suppliers

USDMF

CEP/COS

JDMF

EU WC

KDMF

NDC API

VMF

Listed Suppliers

0INTERMEDIATES

REF. STANDARDS OR IMPURITIES

EDQM

USP

Others

FINISHED DOSAGE FORMULATIONS

FDF Dossiers

FDA Orange Book

Europe

Canada

Australia

South Africa

Listed Dossiers

0 DRUGS IN DEVELOPMENT

DRUG PRODUCT COMPOSITIONS

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

PATENTS & EXCLUSIVITIES

US Patents

US Exclusivities

Health Canada Patents

API REF. PRICE (USD/KG)

$ 0

GLOBAL SALES INFORMATION

US Medicaid (USD)

Annual Reports (USD Million)

Regulatory FDF Prices

API/FDF Prices: Book a Demo to
explore the features and consider
upgrading later

MARKET PLACE

API

FDF

DIGITAL CONTENT

Data Compilation #PharmaFlow

Stock Recap #PipelineProspector

Weekly News Recap #Phispers

News #PharmaBuzz

Chemistry

Click the arrow to open the dropdown

Click the button for full data set

Also known as:

Molecular Formula

C₁₀₁H₁₅₂N₁₄O₂₇

Molecular Weight

1994.4 g/mol

InChI Key

ZTHJLYVWKNLZAD-QZPNKMJMSA-N

1 2D Structure

Urcosimod

2 Identification

2.1 Computed Descriptors

2.1.1 IUPAC Name

(2S)-2-[[(3S)-2-[(2R)-2-[[(2S)-2-[[(2S)-5-amino-2-[[(2R)-2-[[(2S)-1-[(2S)-2-[[(2S)-2-[[(2R)-2-[[2-[[2-[3-[2-[2-[2-[2-[2-[2-[2-[2-(hexadecanoylamino)ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]propanoylamino]acetyl]amino]acetyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]pyrrolidine-2-carbonyl]amino]-3-hydroxypropanoyl]amino]-5-oxopentanoyl]amino]-3-phenylpropanoyl]amino]propanoyl]-3,4-dihydro-1H-isoquinoline-3-carbonyl]amino]-3-hydroxypropanoic acid

2.1.2 InChI

InChI=1S/C101H152N14O27/c1-5-6-7-8-9-10-11-12-13-14-15-16-23-34-88(120)103-42-45-136-47-49-138-51-53-140-55-57-142-59-58-141-56-54-139-52-50-137-48-46-135-44-41-89(121)104-65-90(122)105-66-91(123)107-79(63-74-35-37-77(118)38-36-74)94(126)110-81(62-73-29-21-18-22-30-73)95(127)111-82(60-70(2)3)100(132)114-43-26-33-85(114)97(129)112-83(68-116)96(128)108-78(39-40-87(102)119)92(124)109-80(61-72-27-19-17-20-28-72)93(125)106-71(4)99(131)115-67-76-32-25-24-31-75(76)64-86(115)98(130)113-84(69-117)101(133)134/h17-22,24-25,27-32,35-38,70-71,78-86,116-118H,5-16,23,26,33-34,39-69H2,1-4H3,(H2,102,119)(H,103,120)(H,104,121)(H,105,122)(H,106,125)(H,107,123)(H,108,128)(H,109,124)(H,110,126)(H,111,127)(H,112,129)(H,113,130)(H,133,134)/t71-,78+,79-,80+,81+,82+,83-,84+,85+,86+/m1/s1

2.1.3 InChI Key

ZTHJLYVWKNLZAD-QZPNKMJMSA-N

2.2 Create Date

2025-04-24

3 Chemical and Physical Properties

Molecular Formula	C₁₀₁H₁₅₂N₁₄O₂₇
Molecular Weight	1994.4 g/mol
XLogP3	5.5
Hydrogen Bond Donor Count	16
Hydrogen Bond Acceptor Count	27
Rotatable Bond Count	76
Exact Mass	Da
Monoisotopic Mass	Da
Topological Polar Surface Area	576
Heavy Atom Count	142
Formal Charge	0
Complexity	3710
Isotope Atom Count	0
Defined Atom Stereocenter Count	10
Undefined Atom Stereocenter Count	0
Defined Bond Stereocenter Count	0
Undefined Bond Stereocenter Count	0
Covalently Bonded Unit Count	1

ABOUT THIS PAGE

Find Urcosimod manufacturers, exporters & distributors on PharmaCompass

Urcosimod

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

0INTERMEDIATES

REF. STANDARDS OR IMPURITIES

FINISHED DOSAGE FORMULATIONS

0 DRUGS IN DEVELOPMENT

DRUG PRODUCT COMPOSITIONS

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

PATENTS & EXCLUSIVITIES

API REF. PRICE (USD/KG)

$ 0

GLOBAL SALES INFORMATION

MARKET PLACE

DIGITAL CONTENT

What are you looking for?